Lenalidomide-based triplet regimens in first relapsed multiple myeloma patients: real-world evidence from a propensity score matched analysis.
Mangiacavalli S, Cartia CS, Galli M, Pezzatti S, Belotti A, Fazio F, Mina R, Marcatti M, Cafro A, Zambello R, Paris L, Barilà G, Olivares C, Pompa A, Mazza R, Farina F, Soldarini M, Benvenuti P, Pagani G, Palumbo M, Masoni V, Ferretti VV, Klersy C, Arcaini L, Petrucci MT.
Mangiacavalli S, et al. Among authors: soldarini m.
Haematologica. 2023 Mar 1;108(3):833-842. doi: 10.3324/haematol.2022.281342.
Haematologica. 2023.
PMID: 36200419
Free PMC article.